Heparan sulfate-independent infection attenuates high-neurovirulence GDVII virus-induced encephalitis

Journal of Virology

Volumn 78, Issue 16, 2004, Pages 8909-8916

  Reddi, Honey V ^a   Kumar, A S Manoj ^a   Kung, Aisha Y ^a   Kallio, Patricia D ^a   Schlitt, Brian P ^a   Lipton, Howard L ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b EVANSTON HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARAN SULFATE; SIALIC ACID; VIRUS RNA;

ADAPTATION; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CELL STRAIN BHK; CHO CELL; CONTROLLED STUDY; MACROPHAGE; MOUSE; MURINE ENCEPHALOMYELITIS VIRUS; NEUROBLASTOMA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLIOMYELITIS; PRIORITY JOURNAL; SPINAL CORD VENTRAL HORN; VIROGENESIS; VIRUS CAPSID; VIRUS CELL INTERACTION; VIRUS ENCEPHALITIS; VIRUS STRAIN; VIRUS VIRULENCE;

AMINO ACID SUBSTITUTION; ANIMALS; BRAIN; CARDIOVIRUS INFECTIONS; CELL LINE; CHO CELLS; CRICETINAE; ENCEPHALITIS, VIRAL; HEPARITIN SULFATE; MICE; NEURONS; POLIOMYELITIS; SPINAL CORD; THEILOVIRUS; VIRULENCE;

EID: 3543114270     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.16.8909-8916.2004     Document Type: Article

References (42)

1. Bai, X., G. Wei, A. Sinha, and J. D. Esko. 1999. Chinese hamster ovary cell mutants defective in glycosaminoglycan assembly and glucuronosyltransferase I. J. Biol. Chem. 19:13017-13024.
2. Bernard, K. A., W. B. Klimstra, and R. E. Johnston. 2000. Mutations in the E2 glycoprotein of Venezuelan equine encephalitis virus confer heparan sulfate interaction, low morbidity, and rapid clearance from blood of mice. Virology 276:93-103.
3. Byrnes, A. P., and D. E. Griffin. 2000. Large-plaque mutants of Sindbis virus show reduced binding to heparan sulfate, heightened viremia, and slower clearance from the circulation. J. Virol. 74:644-651.
4. Cardin, A. D., and H. J. R. Weintraub. 1989. Molecular modeling of protein-glycosoaminoglycan interactions. Arteriosclerosis 9:21-32.
5. Denizot, F., and R. Lang. 1986. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods 89:271-277.
6. Feyzi, E., E. Trybala, T. Bergstrom, U. Lindahl, and D. Spillman. 1997. Structural requirement of heparan sulfate for interaction with herpes simplex virus type 1 virions and isolated glycoprotein C. J. Biol. Chem. 272:24850-24857.
7. Fotiadis, C., D. R. Kilpatrick, and H. L. Lipton. 1991. Comparison of the binding characteristics to BHK-21 cells of viruses representing the two Theiler's virus neurovirulence groups. Virology 182:365-370.
8. Friedmann, A., and H. L. Lipton. 1980. Replication of GDVII and DA strains of Theiler's murine encephalomyelitis virus in BHK 21 cells: an electron microscopic study. Virology 101:389-398.
9. Fry, E. E., S. M. Lea, T. Jackson, J. W. Newman, F. M. Ellard, W. E. Blakemore, R. Abu Ghazaleh, A. Samuel, A. M. Q. King, and D. I. Stuart. 1999. The structure and function of a foot-and-mouth disease-virus oligosaccharide receptor complex. EMBO J. 18:543-554.
10. Goto, A., D. Hayasaka, K. Yoshii, T. Mizutani, H. Kariwa, and I. Takashima. 2003. A BHK-21 cell culture-adapted tick-borne encephalitis virus mutant is attenuated for neuroinvasiveness. Vaccine 21:4043-4051.
11. Guido, D., X. M. Bai, B. Van Der Schueren, J.-J. Cassiman, and H. Van Den Berghe. 1992. Developmental changes in heparan sulfate expression: in situ detection with mAbs. J. Cell Biol. 119:961-975.
12. Hartmann, U., and P. Maurer. 2001. Proteoglycans in the nervous system - the quest for functional roles in vivo. Matrix Biol. 20:23-35.
13. Heil, M. L., A. Albee, J. H. Strauss, and R. J. Kuhn. 2001. An amino acid substitution in the coding region of the E2 glycoprotein adapts Ross River virus to utilize heparan sulfate as an attachment moiety. J. Virol. 75:6303-6309.
14. Herold, B. C., S. I. Gerber, B. J. Belval, A. M. Siston, and N. Shulman. 1996. Differences in the susceptibility of herpes simplex virus types 1 and 2 to modified heparin compounds suggest serotype differences in viral entry. J. Virol. 70:3461-3469.
15. Hileman, R. E., J. R. Fromm, J. M. Weiler, and R. J. Linhardt. 1998. Glycosaminoglycan-protein interactions: definition of consensus sites in glycosaminoglycan binding proteins. BioEssays 20:156-167.
16. Hulst, M. M., H. G. van Gennip, A. C. Vlot, E. Schooten, A. J. de Smit, and R. J. Moormann. 2001. Interaction of classical swine fever virus with membrane-associated heparan sulfate: role for virus replication in vivo and virulence. J. Virol. 75:9585-9595.
17. Jelachich, M. L., C. Brumlage, and H. L. Lipton. 1999. Differentiation of M1 myeloid precursor cells into macrophages results in binding and infection by Theiler's murine encephalomyelitis virus (TMEV) and apoptosis. J. Virol. 73:3227-3235.
18. Jinno-Oue, A., M. Oue, and S. K. Ruscetti. 2001. A unique heparin-binding domain in the envelope protein of the neuropathogenic PVC-211 murine leukemia virus may contribute to its brain capillary endothelial cell tropism. J. Virol. 75:12439-12445.
19. Jnaoui, K., and T. Michiels. 1999. Analysis of cellular mutants resistant to Theiler's virus infection: differential infection of L929 cells by persistent and neurovirulent strains. J. Virol. 73:7248-7254.
20. Jnaoui, K., M. Minet, and T. Michiels. 2002. Mutations that affect the tropism of DA and GDVII strains of Theiler's virus in vitro influence sialic acid binding and pathogenesis. J. Virol. 76:8138-8147.
21. Kilpatrick, D. R., and H. L. Lipton. 1991. Predominant binding of Theiler's viruses to a 34-kilodalton receptor protein on susceptible cell lines. J. Virol. 65:5244-5249.
22. Klimstra, W. B., K. D. Ryman, and R. E. Johnston. 1998. Adaptation of Sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor. J. Virol. 72:7357-7366.
23. Lee, E., and M. Lobigs. 2000. Substitutions at the putative receptor-binding site of an encephalitic flavivirus alter virulence and host cell tropism and reveal a role for glycosaminoglycans in entry. J. Virol. 74:8867-8875.
24. Lee, E., and M. Lobigs. 2002. Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray Valley encephalitis virus. J. Virol. 76:4901-4911.
25. Lee, P., R. Knight, J. M. Smit, J. Wilschut, and D. E. Griffin. 2002. A single mutation in the E2 glycoprotein important for neurovirulence influences binding of Sindbis virus to neuroblastoma cells. J. Virol. 76:6302-6310.
26. Lehrich, J. R., B. G. W. Arnason, and F. H. Hochberg. 1976. Demyelinating myelopathy in mice induced by the DA virus. J. Neurol. Sci. 29:149-160.
27. Libbey, J. E., I. J. McCright, I. Tsunoda, Y. Wada, and R. S. Fujinami. 2001. Peripheral nerve protein, PO, as a potential receptor for Theiler's murine encephalomyelitis virus. J. Neurovirol. 7:97-104.
28. Lipton, H. L. 1975. Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination. Infect. Immun. 11:1147-1155.
29. Lipton, H. L., G. Twaddle, and M. L. Jelachich. 1995. The predominant virus antigen burden is present in macrophages in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. J. Virol. 69:2525-2533.
30. Liu, J., Z. Shriver, R. M. Pope, S. C. Thorp, M. B. Duncan, R. J. Copeland, C. S. Raska, K. Yoshida, R. J. Eisenberg, G. Cohen, R. J. Linhardt, and R. Sasisekharan. 2002. Characterization of a heparan sulfate octasaccharide that binds to herpes simplex type 1 glycoprotein D. J. Biol. Chem. 277:33456-33467.
31. Luo, M., K. S. Totb, L. Zhou, A. Pritchard, and H. L. Lipton. 1996. The structure of a highly virulent Theiler's murine encephalomyelitis virus (GDVII) and implications for determinants of viral persistence. Virology 220:246-250.
32. Mandl, C. W., H. Kroschewski, S. L. Allison, R. Kofler, H. Holzmann, T. Meixner, and F. X. Heniz. 2001. Adaptation of tick-borne encephalitis virus to BHK-21 cells results in the formation of multiple heparan sulfate binding sites in the envelope protein and attenuation in vivo. J. Virol. 75:5627-5637.
33. Michiels, T., N. Jarousse, and M. Brahic. 1995. Analysis of the leader and capsid coding regions of persistent and neurovirulent strains of Theiler's virus. Virology 214:550-558.
34. Perrimon, N., and M. Bernfield. 2000. Specificities of heparan sulphate proteoglycans in developmental processes. Nature 404:725-728.
35. Reddi, H. V., and H. L. Lipton. 2002. Heparan sulfate mediates infection of high-neurovirulence Theiler's viruses. J. Virol. 76:8400-8407.
36. Reed, L. J., and H. A. Muench. 1938. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27:493-497.
37. Rozhon, E. J., J. D. Kratochvil, and H. L. Lipton. 1983. Analysis of genetic variation in Theiler's virus during persistent infection in the mouse central nervous system. Virology 128:16-32.
38. Sa-Carvalho, D., E. Rieder, B. Baxt, R. Rodarte, A. Tanuri, and P. W. Mason. 1997. Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle. J. Virol. 71:5115-5123.
39. Shah, A. H., and H. L. Lipton. 2002. Low-neurovirulence Theiler's viruses use sialic acid moieties on N-linked oligosaccharide structures for attachment. Virology 304:443-450.
40. Shukla, D., J. Liu, P. Blaiklock, N. W. Shworak, X. Bai, J. D. Esko, G. H. Cohen, R. D. Eisenherg, and P. G. Spear. 1999. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 99:13-22.
41. Zhao, Q., J. M. Pacheco, and P. W. Mason. 2003. Evaluation of genetically engineered derivatives of a Chinese strain of foot-and-mouth disease virus reveal a novel cell-binding site which functions in cell culture and in animals. J. Virol. 77:3269-3280.
42. Zhou, L., Y. Luo, Y. Wu, J. Tsao, and M. Luo. 2000. Sialylation of the host receptor may modulate entry of demyelinating persistent Theiler's virus. J. Virol. 74:1477-1485.